Bipolar Disorder Market Analysis By Drug Class (Mood stabilizer, Anticonvulsant, Antipsychotic, Antidepressant, Antianxiety), By Mechanism of Action, By Region, And Segment Forecasts, 2018 - 2025

Report ID: GVR-2-68038-033-0
Number of Pages: 95
Format: Electronic (PDF)

Historical Range: 2014 - 2016
Industry: Healthcare

Market Segmentation

Global Bipolar disorder: Drug Class Outlook (Revenue, USD Million, 2014 - 2025)
- Mood stabilizer
- Anticonvulsants
- Antipsychotic drugs
- Antidepressant drugs
- Antianxiety drugs
Global Bipolar disorder: Mechanism of Action Outlook (Revenue, USD Million, 2014 - 2025)
- Selective serotonin reuptake inhibitor
- Serotonin norepinephrine reuptake inhibitor
- Tricyclic antidepressant drugs
- Monoamine oxidase inhibitors
- Benzodiazepines
- Beta blockers
- Others
Bipolar disorder: Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
  - U.S.
    - U.S. Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - U.S. Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
  - Canada
    - Canada. Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - Canada. Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
- Europe
  - UK
    - UK. Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - UK Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
  - Germany
    - Germany Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - Germany Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
    - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
- Asia Pacific
  - Japan
    - Japan Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - Japan Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
  - China
    - China Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - China Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
- Latin America
  - Brazil
    - Brazil Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - Brazil Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
  - Mexico
    - Mexico Bipolar Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - Mexico Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
- MEA
  - South Africa
    - South Africa Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - South Africa Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other
  - Saudi Arabia
    - Saudi Arabia Disorder Market, by Drug class (USD Million), 2014 - 2025
      - Mood stabilizer
      - Anticonvulsant
      - Antipsychotic drugs
      - Antidepressant drugs
      - Antianxiety drugs
    - Saudi Arabia Bipolar Disorder Market, by Mechanism of action (USD Million), 2014 - 2025
      - Selective serotonin reuptake inhibitor
      - Serotonin norepinephrine reuptake inhibitor
      - Tricyclic antidepressants
      - Monoamine oxidase inhibitors
      - benzodiazepines
      - Beta blockers
      - Other

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.